Marshall Wace North America L.P. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2021$42,070,000
+2033.4%
409,205
+1725.7%
0.18%
+2137.5%
Q2 2021$1,972,000
+254.0%
22,413
+351.0%
0.01%
+166.7%
Q4 2020$557,000
-37.8%
4,970
-56.7%
0.00%
-50.0%
Q2 2020$896,000
-57.5%
11,481
-68.1%
0.01%
-62.5%
Q1 2020$2,106,000
-95.0%
36,026
-93.2%
0.02%
-89.3%
Q1 2019$42,210,000
+805.4%
527,296
+782.7%
0.15%
+837.5%
Q3 2018$4,662,000
+273.0%
59,736
+143.7%
0.02%
+77.8%
Q2 2017$1,250,000
+109.4%
24,515
+64.2%
0.01%
+80.0%
Q1 2017$597,00014,9330.01%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders